Global Bronchopulmonary Dysplasia Market Research Report 2023

Bronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants. Lungs and bronchi are damaged at the neonatal phase which causes destruction of tiny air sacs known as alveoli. Babies are not born with the disease. The condition is developed when premature infants need aid to breathe for a longer period, leading to inflammation and lung scarring. Infants with this disease exhibit signs and symptoms such as rapid breathing and faster heart rate. The disease is life threatening however, the severity of the disease varies.

The global Bronchopulmonary Dysplasia market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The global bronchopulmonary dysplasia treatment market is expected to expand at a steady CAGR during the forecast period. According to the Journal of Clinical Medicine, 10,000 to 15,000 new cases of the disorder are reported each year in the U.S. alone. High prevalence of the diseases is expected to drive the global bronchopulmonary dysplasia treatment market during the forecast period. According to the WHO, 15 million babies are born preterm which is another factor contributing to the growth of the market. Furthermore, government initiatives, favorable reimbursement policies, launch of novel drugs, strong pipeline, rising premature birth cases, and increase in health care expenditure are factors likely to propel the global bronchopulmonary dysplasia treatment market during the forecast period. Long-term side effects of drugs, high cost of treatment, and lack of awareness in developing countries are factors anticipated to restrain the global market during the forecast period.

This report aims to provide a comprehensive presentation of the global market for Bronchopulmonary Dysplasia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchopulmonary Dysplasia.

The Bronchopulmonary Dysplasia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bronchopulmonary Dysplasia market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bronchopulmonary Dysplasia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Surfactant Replacement Therapy

1.2.3 Oxygen Therapy

1.2.4 Supportive Therapy

1.2.5 Others

1.3 Market by Application

1.3.1 Global Bronchopulmonary Dysplasia Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Bronchopulmonary Dysplasia Market Perspective (2018-2029)

2.2 Bronchopulmonary Dysplasia Growth Trends by Region

2.2.1 Global Bronchopulmonary Dysplasia Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Bronchopulmonary Dysplasia Historic Market Size by Region (2018-2023)

2.2.3 Bronchopulmonary Dysplasia Forecasted Market Size by Region (2024-2029)

2.3 Bronchopulmonary Dysplasia Market Dynamics

2.3.1 Bronchopulmonary Dysplasia Industry Trends

2.3.2 Bronchopulmonary Dysplasia Market Drivers

2.3.3 Bronchopulmonary Dysplasia Market Challenges

2.3.4 Bronchopulmonary Dysplasia Market Restraints

3.1 Global Top Bronchopulmonary Dysplasia Players by Revenue

3.1.1 Global Top Bronchopulmonary Dysplasia Players by Revenue (2018-2023)

3.1.2 Global Bronchopulmonary Dysplasia Revenue Market Share by Players (2018-2023)

3.2 Global Bronchopulmonary Dysplasia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Bronchopulmonary Dysplasia Revenue

3.4 Global Bronchopulmonary Dysplasia Market Concentration Ratio

3.4.1 Global Bronchopulmonary Dysplasia Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bronchopulmonary Dysplasia Revenue in 2022

3.5 Bronchopulmonary Dysplasia Key Players Head office and Area Served

3.6 Key Players Bronchopulmonary Dysplasia Product Solution and Service

3.7 Date of Enter into Bronchopulmonary Dysplasia Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Bronchopulmonary Dysplasia Historic Market Size by Type (2018-2023)

4.2 Global Bronchopulmonary Dysplasia Forecasted Market Size by Type (2024-2029)

5.1 Global Bronchopulmonary Dysplasia Historic Market Size by Application (2018-2023)

5.2 Global Bronchopulmonary Dysplasia Forecasted Market Size by Application (2024-2029)

6.1 North America Bronchopulmonary Dysplasia Market Size (2018-2029)

6.2 North America Bronchopulmonary Dysplasia Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Bronchopulmonary Dysplasia Market Size by Country (2018-2023)

6.4 North America Bronchopulmonary Dysplasia Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Bronchopulmonary Dysplasia Market Size (2018-2029)

7.2 Europe Bronchopulmonary Dysplasia Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Bronchopulmonary Dysplasia Market Size by Country (2018-2023)

7.4 Europe Bronchopulmonary Dysplasia Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Bronchopulmonary Dysplasia Market Size (2018-2029)

8.2 Asia-Pacific Bronchopulmonary Dysplasia Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2018-2023)

8.4 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Bronchopulmonary Dysplasia Market Size (2018-2029)

9.2 Latin America Bronchopulmonary Dysplasia Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Bronchopulmonary Dysplasia Market Size by Country (2018-2023)

9.4 Latin America Bronchopulmonary Dysplasia Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Bronchopulmonary Dysplasia Market Size (2018-2029)

10.2 Middle East & Africa Bronchopulmonary Dysplasia Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2018-2023)

10.4 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Chiesi Farmaceutici

11.1.1 Chiesi Farmaceutici Company Detail

11.1.2 Chiesi Farmaceutici Business Overview

11.1.3 Chiesi Farmaceutici Bronchopulmonary Dysplasia Introduction

11.1.4 Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2018-2023)

11.1.5 Chiesi Farmaceutici Recent Development

11.2 Discovery Laboratories

11.2.1 Discovery Laboratories Company Detail

11.2.2 Discovery Laboratories Business Overview

11.2.3 Discovery Laboratories Bronchopulmonary Dysplasia Introduction

11.2.4 Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2018-2023)

11.2.5 Discovery Laboratories Recent Development

11.3 Takeda Pharmaceutical Company

11.3.1 Takeda Pharmaceutical Company Company Detail

11.3.2 Takeda Pharmaceutical Company Business Overview

11.3.3 Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Introduction

11.3.4 Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2018-2023)

11.3.5 Takeda Pharmaceutical Company Recent Development

11.4 MediPost

11.4.1 MediPost Company Detail

11.4.2 MediPost Business Overview

11.4.3 MediPost Bronchopulmonary Dysplasia Introduction

11.4.4 MediPost Revenue in Bronchopulmonary Dysplasia Business (2018-2023)

11.4.5 MediPost Recent Development

11.5 Clarassance

11.5.1 Clarassance Company Detail

11.5.2 Clarassance Business Overview

11.5.3 Clarassance Bronchopulmonary Dysplasia Introduction

11.5.4 Clarassance Revenue in Bronchopulmonary Dysplasia Business (2018-2023)

11.5.5 Clarassance Recent Development

11.6 Syntrix Biosystems

11.6.1 Syntrix Biosystems Company Detail

11.6.2 Syntrix Biosystems Business Overview

11.6.3 Syntrix Biosystems Bronchopulmonary Dysplasia Introduction

11.6.4 Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2018-2023)

11.6.5 Syntrix Biosystems Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Surfactant Replacement Therapy

    Table 3. Key Players of Oxygen Therapy

    Table 4. Key Players of Supportive Therapy

    Table 5. Key Players of Others

    Table 6. Global Bronchopulmonary Dysplasia Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Bronchopulmonary Dysplasia Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Bronchopulmonary Dysplasia Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Bronchopulmonary Dysplasia Market Share by Region (2018-2023)

    Table 10. Global Bronchopulmonary Dysplasia Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Bronchopulmonary Dysplasia Market Share by Region (2024-2029)

    Table 12. Bronchopulmonary Dysplasia Market Trends

    Table 13. Bronchopulmonary Dysplasia Market Drivers

    Table 14. Bronchopulmonary Dysplasia Market Challenges

    Table 15. Bronchopulmonary Dysplasia Market Restraints

    Table 16. Global Bronchopulmonary Dysplasia Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Bronchopulmonary Dysplasia Market Share by Players (2018-2023)

    Table 18. Global Top Bronchopulmonary Dysplasia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchopulmonary Dysplasia as of 2022)

    Table 19. Ranking of Global Top Bronchopulmonary Dysplasia Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Bronchopulmonary Dysplasia Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Bronchopulmonary Dysplasia Product Solution and Service

    Table 23. Date of Enter into Bronchopulmonary Dysplasia Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Bronchopulmonary Dysplasia Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Bronchopulmonary Dysplasia Revenue Market Share by Type (2018-2023)

    Table 27. Global Bronchopulmonary Dysplasia Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Bronchopulmonary Dysplasia Revenue Market Share by Type (2024-2029)

    Table 29. Global Bronchopulmonary Dysplasia Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Bronchopulmonary Dysplasia Revenue Market Share by Application (2018-2023)

    Table 31. Global Bronchopulmonary Dysplasia Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Bronchopulmonary Dysplasia Revenue Market Share by Application (2024-2029)

    Table 33. North America Bronchopulmonary Dysplasia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Bronchopulmonary Dysplasia Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Bronchopulmonary Dysplasia Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Bronchopulmonary Dysplasia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Bronchopulmonary Dysplasia Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Bronchopulmonary Dysplasia Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Bronchopulmonary Dysplasia Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Bronchopulmonary Dysplasia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Bronchopulmonary Dysplasia Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Bronchopulmonary Dysplasia Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Bronchopulmonary Dysplasia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Chiesi Farmaceutici Company Detail

    Table 49. Chiesi Farmaceutici Business Overview

    Table 50. Chiesi Farmaceutici Bronchopulmonary Dysplasia Product

    Table 51. Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2018-2023) & (US$ Million)

    Table 52. Chiesi Farmaceutici Recent Development

    Table 53. Discovery Laboratories Company Detail

    Table 54. Discovery Laboratories Business Overview

    Table 55. Discovery Laboratories Bronchopulmonary Dysplasia Product

    Table 56. Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2018-2023) & (US$ Million)

    Table 57. Discovery Laboratories Recent Development

    Table 58. Takeda Pharmaceutical Company Company Detail

    Table 59. Takeda Pharmaceutical Company Business Overview

    Table 60. Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Product

    Table 61. Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2018-2023) & (US$ Million)

    Table 62. Takeda Pharmaceutical Company Recent Development

    Table 63. MediPost Company Detail

    Table 64. MediPost Business Overview

    Table 65. MediPost Bronchopulmonary Dysplasia Product

    Table 66. MediPost Revenue in Bronchopulmonary Dysplasia Business (2018-2023) & (US$ Million)

    Table 67. MediPost Recent Development

    Table 68. Clarassance Company Detail

    Table 69. Clarassance Business Overview

    Table 70. Clarassance Bronchopulmonary Dysplasia Product

    Table 71. Clarassance Revenue in Bronchopulmonary Dysplasia Business (2018-2023) & (US$ Million)

    Table 72. Clarassance Recent Development

    Table 73. Syntrix Biosystems Company Detail

    Table 74. Syntrix Biosystems Business Overview

    Table 75. Syntrix Biosystems Bronchopulmonary Dysplasia Product

    Table 76. Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2018-2023) & (US$ Million)

    Table 77. Syntrix Biosystems Recent Development

    Table 78. Research Programs/Design for This Report

    Table 79. Key Data Information from Secondary Sources

    Table 80. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Bronchopulmonary Dysplasia Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Bronchopulmonary Dysplasia Market Share by Type: 2022 VS 2029

    Figure 3. Surfactant Replacement Therapy Features

    Figure 4. Oxygen Therapy Features

    Figure 5. Supportive Therapy Features

    Figure 6. Others Features

    Figure 7. Global Bronchopulmonary Dysplasia Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Bronchopulmonary Dysplasia Market Share by Application: 2022 VS 2029

    Figure 9. Clinic Case Studies

    Figure 10. Hospital Case Studies

    Figure 11. Others Case Studies

    Figure 12. Bronchopulmonary Dysplasia Report Years Considered

    Figure 13. Global Bronchopulmonary Dysplasia Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Bronchopulmonary Dysplasia Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Bronchopulmonary Dysplasia Market Share by Region: 2022 VS 2029

    Figure 16. Global Bronchopulmonary Dysplasia Market Share by Players in 2022

    Figure 17. Global Top Bronchopulmonary Dysplasia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchopulmonary Dysplasia as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Bronchopulmonary Dysplasia Revenue in 2022

    Figure 19. North America Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Bronchopulmonary Dysplasia Market Share by Country (2018-2029)

    Figure 21. United States Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Bronchopulmonary Dysplasia Market Share by Country (2018-2029)

    Figure 25. Germany Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Bronchopulmonary Dysplasia Market Share by Region (2018-2029)

    Figure 33. China Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Bronchopulmonary Dysplasia Market Share by Country (2018-2029)

    Figure 41. Mexico Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Bronchopulmonary Dysplasia Market Share by Country (2018-2029)

    Figure 45. Turkey Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Bronchopulmonary Dysplasia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Chiesi Farmaceutici Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2018-2023)

    Figure 48. Discovery Laboratories Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2018-2023)

    Figure 49. Takeda Pharmaceutical Company Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2018-2023)

    Figure 50. MediPost Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2018-2023)

    Figure 51. Clarassance Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2018-2023)

    Figure 52. Syntrix Biosystems Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2018-2023)

    Figure 53. Bottom-up and Top-down Approaches for This Report

    Figure 54. Data Triangulation

    Figure 55. Key Executives Interviewed